Frequency and topography of cerebral microbleeds in dementia with Lewy bodies compared to Alzheimer's disease.

[1]  J. Nagasawa,et al.  Prevalence and clinicoradiological analyses of patients with Alzheimer disease coexisting multiple microbleeds. , 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[2]  C. Jack,et al.  Focal hemosiderin deposits and β-amyloid load in the ADNI cohort , 2013, Alzheimer's & Dementia.

[3]  C. Jack,et al.  Focal hemosiderin deposits and beta-amyloid load in the ADNI cohort , 2013, Alzheimer's & Dementia.

[4]  R. Kinno,et al.  Prevalence and Clinical Implication of Microbleeds in Dementia with Lewy Bodies in Comparison with Microbleeds in Alzheimer's Disease , 2013, Dementia and Geriatric Cognitive Disorders Extra.

[5]  R. Sperling,et al.  Inflammatory cerebral amyloid angiopathy and amyloid‐modifying therapies: Variations on the Same ARIA? , 2013, Annals of neurology.

[6]  C. Jack,et al.  Multimodality imaging characteristics of dementia with Lewy bodies , 2012, Neurobiology of Aging.

[7]  Nick C Fox,et al.  Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis , 2012, The Lancet Neurology.

[8]  D. Werring,et al.  Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum , 2011, Journal of Neurology, Neurosurgery & Psychiatry.

[9]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.

[10]  V L Villemagne,et al.  Cerebral microhemorrhage and brain β-amyloid in aging and Alzheimer disease , 2011, Neurology.

[11]  Clifford R. Jack,et al.  Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup , 2011, Alzheimer's & Dementia.

[12]  N. Cairns,et al.  In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia , 2010, Neurology.

[13]  Steven Warach,et al.  Cerebral Microbleeds : A Field Guide to their Detection and Interpretation , 2012 .

[14]  C. Rowe,et al.  Amyloid load in Parkinson’s disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[15]  Gregory M. Szilagyi,et al.  Microbleed topography, leukoaraiosis, and cognition in probable Alzheimer disease from the Sunnybrook dementia study. , 2008, Archives of neurology.

[16]  Keith A. Johnson,et al.  Imaging of amyloid burden and distribution in cerebral amyloid angiopathy , 2007, Annals of neurology.

[17]  J. Wardlaw,et al.  Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting. , 2007, Brain : a journal of neurology.

[18]  M. Onofrj,et al.  Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium , 2006, Neurology.

[19]  K. Jellinger,et al.  Alzheimer’s disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy , 2005, Acta Neuropathologica.

[20]  N. Tzourio-Mazoyer,et al.  Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain , 2002, NeuroImage.

[21]  W. Marsden.  I and J , 2012 .

[22]  A. Verma,et al.  Imaging of Amyloid Burden and Distribution in Cerebral Amyloid Angiopathy , 2008 .